These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7758140)

  • 1. [Perinatal pharmacotherapy and the risk of functional teratogenic defects].
    Benesová O; Tejkalová H; Kristofiková Z; Dostál M; Husek P
    Cesk Fysiol; 1995 Mar; 44(1):11-4. PubMed ID: 7758140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perinatal drug administration and risks of functional teratogenic defects].
    Benesová O
    Cas Lek Cesk; 1994 Jan; 133(3):67-70. PubMed ID: 8137374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain.
    Benesová O; Pavlík A
    Neuropharmacology; 1989 Jan; 28(1):89-97. PubMed ID: 2927582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain maldevelopment and delayed neuro-behavioural deviations, induced by perinatal insults, and possibilities of their prevention.
    Benesová O
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):373-80. PubMed ID: 6663069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Personal experience with monitoring drug prescriptions in pregnancy].
    Barnetová L; Martínková J; Stránská V; Nováková A; Faltová V; Malecková M; Odrázková E; Grätz R; Fajmanová M; Martínková J
    Cesk Gynekol; 1989 Sep; 54(8):561-74. PubMed ID: 2582500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Teratogenic effects of etretinate in humans].
    Happle R; Traupe H; Bounameaux Y; Fisch T
    Dtsch Med Wochenschr; 1984 Sep; 109(39):1476-80. PubMed ID: 6479047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment of drug use in pregnancy: prevention of birth defects.
    Peters PW
    Ann Ist Super Sanita; 1993; 29(1):131-7. PubMed ID: 8129259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the teratogenic potential of diazepam and SCH 12041.
    Beall JR
    Can Med Assoc J; 1972 May; 106(10):1061. PubMed ID: 5032135
    [No Abstract]   [Full Text] [Related]  

  • 9. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of drug-induced congenital defects.
    De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural teratogenic risk of perinatal administration of dexamethasone in combinations with phenoterol.
    Tejkalová H; Benesová O; Kristofíková Z; Binková B; Dlohozková N; Buresová M
    Act Nerv Super (Praha); 1989 Oct; 31(3):226-7. PubMed ID: 2588985
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study.
    Habermann F; Fritzsche J; Fuhlbrück F; Wacker E; Allignol A; Weber-Schoendorfer C; Meister R; Schaefer C
    J Clin Psychopharmacol; 2013 Aug; 33(4):453-62. PubMed ID: 23764684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy during pregnancy. Teratological aspects (author's transl)].
    Held KR
    MMW Munch Med Wochenschr; 1981 Aug; 123(32-33):1235-8. PubMed ID: 6790971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of the behavioural teratogenic risk of the tocolytic drug phenoterol.
    Tejkalová H; Benesová O; Kristofíková Z; Binková B; Dlohozková N; Buresová M
    Homeost Health Dis; 1991; 33(1-2):89-93. PubMed ID: 1817695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-immuno-teratogenicity of drugs used in neonatal pharmacotherapy in relation to the ontogenic stage at the time of their administration.
    Benesová O; Tejkalová H; Kristofiková Z; Panajotova V; Husek P
    Gen Physiol Biophys; 1999 Oct; 18 Spec No():21-7. PubMed ID: 10703715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perinatal administration of drugs and risk of functional teratogenic defects].
    Kucerová M
    Cas Lek Cesk; 1994 Jun; 133(13):412. PubMed ID: 8062335
    [No Abstract]   [Full Text] [Related]  

  • 17. Old and new anti-epileptic drugs in pregnancy.
    Regesta G; Tanganelli P
    Saudi Med J; 2000 Jan; 21(1):18-23. PubMed ID: 11533745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epilepsy and pregnancy. Risks and benefits of anticonvulsant treatment].
    Torres LC; Félix R; Canún S; Mazón JJ
    Ginecol Obstet Mex; 1995 Jul; 63():282-6. PubMed ID: 7665113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and molecular teratology of fetal hydantoin syndrome.
    Buehler BA; Rao V; Finnell RH
    Neurol Clin; 1994 Nov; 12(4):741-8. PubMed ID: 7845340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current aspects of D-penicillamine and pregnancy].
    Miehle W
    Z Rheumatol; 1988; 47 Suppl 1():20-3. PubMed ID: 3063004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.